CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
A randomized controlled trial (RCT) to assess the safety and efficacy of use of Control-IQ technology in adults with type 2 diabetes using b...
Portland, Oregon, United States and 20 other locations
The continual glucose is going to increase time-in-range compared to the standard method in women with gestational diabetes...
Portland, Oregon, United States
of hypercortisolism in a population with difficult to control type 2 diabetes (T2D) (hemoglobin A1c ≥7.5%) despite receiving standard-of-car...
Phase 4
Portland, Oregon, United States and 35 other locations
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...
Phase 2
Portland, Oregon, United States and 58 other locations
weight in adult participants with obesity or overweight and type 2 diabetes. The study will last about 77 weeks and may include up to 22 vis...
Phase 3
Portland, Oregon, United States and 138 other locations
decrease in the kidneys' ability to work properly, and type 1 diabetes.In people with type 1 diabetes, the body does not make enoug...
Phase 3
Portland, Oregon, United States and 80 other locations
The primary objective of the study is to determine if treatment with high-dose aflibercept (HD) at intervals of 12 or 16 weeks provides non-inferior...
Phase 2, Phase 3
Portland, Oregon, United States and 137 other locations
fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community ...
Phase 3
Portland, Oregon, United States and 59 other locations
cord tissue TTAX01 to the surface of a well debrided, complex diabetic foot ulcer (DFU) will, with concomitant management of infection, will...
Phase 3
Portland, Oregon, United States and 15 other locations
The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabetes...
Phase 3
Portland, Oregon, United States of America and 390 other locations
Clinical trials
Research sites
Resources
Legal